{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:04:50Z","timestamp":1781780690737,"version":"3.54.5"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T00:00:00Z","timestamp":1506297600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"crossref","award":["2016097"],"award-info":[{"award-number":["2016097"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s40263-017-0469-1","type":"journal-article","created":{"date-parts":[[2017,9,25]],"date-time":"2017-09-25T15:56:09Z","timestamp":1506354969000},"page":"991-997","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study"],"prefix":"10.1007","volume":"31","author":[{"given":"Robert L.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore","family":"Haslemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole A.","family":"Andreassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Eliasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja-Liisa","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olav","family":"Spigset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6190-2751","authenticated-orcid":false,"given":"Espen","family":"Molden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,25]]},"reference":[{"key":"469_CR1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht S, Cipriani A, Spineli L, Mavridis D, Orey D, Richter F, et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet. 2013;382:951\u201362.","journal-title":"Lancet"},{"key":"469_CR2","first-page":"257","volume":"33","author":"C Benichou","year":"1991","unstructured":"Benichou C, Solal Celigny P. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting. Nouv Rev Fr Hematol. 1991;33:257\u201362.","journal-title":"Nouv Rev Fr Hematol"},{"key":"469_CR3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2165\/00023210-199707020-00005","volume":"7","author":"M Pirmohamed","year":"1997","unstructured":"Pirmohamed M, Park K. Mechanism of clozapine-induced agranulocytosis: current status of research and implications for drug development. CNS Drugs. 1997;7:139\u201358.","journal-title":"CNS Drugs"},{"key":"469_CR4","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1055\/s-2000-8359","volume":"33","author":"M Dettling","year":"2000","unstructured":"Dettling M, Sachse C, Muller-Oerlinghausen B, Roots I, Brockmoller J, Rolfs A, et al. Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: no association with myeloperoxidase and cytochrome P4502D6. Pharmacopsychiatry. 2000;33:218\u201320.","journal-title":"Pharmacopsychiatry."},{"key":"469_CR5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2796.2001.00915.x","volume":"250","author":"J Palmblad","year":"2001","unstructured":"Palmblad J, Papadaki HA, Eliopoulos G. Acute and chronic neutropenias. What is new? J Intern Med. 2001;250:476\u201391.","journal-title":"J Intern Med"},{"key":"469_CR6","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0022-3565(25)12206-4","volume":"275","author":"JL Maggs","year":"1995","unstructured":"Maggs JL, Williams D, Pirmohamed M, Park BK. The metabolic formation of reactive intermediates from clozapine, a drug associated with agranulocytosis in man. J Pharmacol Exp Ther. 1995;275:1463\u201375.","journal-title":"J Pharmacol Exp Ther"},{"key":"469_CR7","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0022-3565(25)24566-9","volume":"272","author":"M Pirmohamed","year":"1995","unstructured":"Pirmohamed M, Williams D, Madden S, Templeton E, Park BK. Metabolism and bioactivation of clozapine by human liver in vitro. J Pharmacol Exp Ther. 1995;272:984\u201390.","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"469_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00002018-199200071-00007","volume":"7","author":"SL Gerson","year":"1992","unstructured":"Gerson SL, Meltzer H. Mechanisms of clozapine-induced agranulocytosis. Drug Saf. 1992;7(Suppl 1):17\u201325.","journal-title":"Drug Saf"},{"key":"469_CR9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1365-2141.1994.tb04786.x","volume":"86","author":"SL Gerson","year":"1994","unstructured":"Gerson SL, Arce C, Meltzer HY. N-desmethylclozapine: a clozapine metabolite that suppresses haemopoiesis. Br J Haematol. 1994;86:555\u201361.","journal-title":"Br J Haematol"},{"key":"469_CR10","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0022-3565(24)37177-0","volume":"283","author":"DP Williams","year":"1997","unstructured":"Williams DP, Pirmohamed M, Naisbitt DJ, Maggs JL, Park BK. Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis. J Pharmacol Exp Ther. 1997;283:1375\u201382.","journal-title":"J Pharmacol Exp Ther"},{"key":"469_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","volume":"18","author":"C Lonjou","year":"2008","unstructured":"Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, et al. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genom. 2008;18:99\u2013107.","journal-title":"Pharmacogenet Genom"},{"key":"469_CR12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004714-199610000-00011","volume":"16","author":"T Pollmacher","year":"1996","unstructured":"Pollmacher T, Hinze-Selch D, Mullington J. Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. J Clin Psychopharmacol. 1996;16:403\u20139.","journal-title":"J Clin Psychopharmacol"},{"key":"469_CR13","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1054\/mehy.1998.0734","volume":"53","author":"I Guest","year":"1999","unstructured":"Guest I, Uetrecht J. Drugs that induce neutropenia\/agranulocytosis may target specific components of the stromal cell extracellular matrix. Med Hypotheses. 1999;53:145\u201351.","journal-title":"Med Hypotheses"},{"key":"469_CR14","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1192\/bjp.188.3.255","volume":"188","author":"LR Dunk","year":"2006","unstructured":"Dunk LR, Annan LJ, Andrews CD. Rechallenge with clozapine following leucopenia or neutropenia during previous therapy. Br J Psychiatry. 2006;188:255\u201363.","journal-title":"Br J Psychiatry"},{"key":"469_CR15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/01.jcp.0000162814.99818.bb","volume":"25","author":"C Marchesi","year":"2005","unstructured":"Marchesi C, Paini M, Tamborini S, Ampollini P, Maggini C. Recurrence of clozapine-induced agranulocytosis. J Clin Psychopharmacol. 2005;25:276\u20137.","journal-title":"J Clin Psychopharmacol"},{"key":"469_CR16","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.tpj.6500423","volume":"7","author":"M Dettling","year":"2007","unstructured":"Dettling M, Cascorbi I, Opgen-Rhein C, Schaub R. Clozapine-induced agranulocytosis in schizophrenic Caucasians: confirming clues for associations with human leukocyte class I and II antigens. Pharmacogenom J. 2007;7:325\u201332.","journal-title":"Pharmacogenom J."},{"key":"469_CR17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/136515001300225231","volume":"5","author":"JL Horacek","year":"2001","unstructured":"Horacek JL, Hoschl C, Borzova K, Hendrychova IJ. Clozapine-induced concordant agranulocytosis in monozygotic twins. Int J Psychiatry Clin Pract. 2001;5:71\u20133.","journal-title":"Int J Psychiatry Clin Pract."},{"key":"469_CR18","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1038\/mp.2016.97","volume":"22","author":"SE Legge","year":"2017","unstructured":"Legge SE, Hamshere ML, Ripke S, Pardinas AF, Goldstein JI, Rees E, et al. Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia. Mol Psychiatry. 2017;22:1502\u20131508. doi: 10.1038\/mp.2016.97 .","journal-title":"Mol Psychiatry"},{"key":"469_CR19","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1038\/ncomms5757","volume":"5","author":"JI Goldstein","year":"2014","unstructured":"Goldstein JI, Jarskog LF, Hilliard C, Alfirevic A, Duncan L, Fourches D, et al. Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles. Nat Commun. 2014;5:4757.","journal-title":"Nat Commun."},{"key":"469_CR20","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/archpsyc.1990.01810220061007","volume":"47","author":"JA Lieberman","year":"1990","unstructured":"Lieberman JA, Yunis J, Egea E, Canoso RT, Kane JM, Yunis EJ. HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia. Arch Gen Psychiatry. 1990;47:945\u20138.","journal-title":"Arch Gen Psychiatry"},{"issue":"Suppl 1","key":"469_CR21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00002018-199200071-00005","volume":"7","author":"JJ Yunis","year":"1992","unstructured":"Yunis JJ, Lieberman J, Yunis EJ. Major histocompatibility complex associations with clozapine-induced agranulocytosis. The USA experience. Drug Saf. 1992;7(Suppl 1):7\u20139.","journal-title":"Drug Saf."},{"key":"469_CR22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11920-011-0185-3","volume":"13","author":"NI Chowdhury","year":"2011","unstructured":"Chowdhury NI, Remington G, Kennedy JL. Genetics of antipsychotic-induced side effects and agranulocytosis. Curr Psychiatry Rep. 2011;13:156\u201365.","journal-title":"Curr Psychiatry Rep."},{"issue":"Suppl 1","key":"469_CR23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00002018-199200071-00004","volume":"7","author":"FH Claas","year":"1992","unstructured":"Claas FH, Abbott PA, Witvliet MD, D\u2019Amaro J, Barnes PM, Krupp P. No direct clinical relevance of the human leucocyte antigen (HLA) system in clozapine-induced agranulocytosis. Drug Saf. 1992;7(Suppl 1):3\u20136.","journal-title":"Drug Saf"},{"key":"469_CR24","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jaad.2007.08.036","volume":"58","author":"S Halevy","year":"2008","unstructured":"Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes Bavinck JN, Sidoroff A, et al. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol. 2008;58:25\u201332.","journal-title":"J Am Acad Dermatol"},{"key":"469_CR25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/JCP.0000000000000387","volume":"35","author":"J Lee","year":"2015","unstructured":"Lee J, Takeuchi H, Fervaha G, Powell V, Bhaloo A, Bies R, et al. The effect of clozapine on hematological indices: a 1-year follow-up study. J Clin Psychopharmacol. 2015;35:510\u20136.","journal-title":"J Clin Psychopharmacol"},{"key":"469_CR26","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/01.CCM.0000109453.57709.E2","volume":"32","author":"JH Crawford","year":"2004","unstructured":"Crawford JH, Yang S, Zhou M, Simms HH, Wang P. Down-regulation of hepatic CYP1A2 plays an important role in inflammatory responses in sepsis. Crit Care Med. 2004;32:502\u20138.","journal-title":"Crit Care Med"},{"key":"469_CR27","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0140-6736(78)90305-7","volume":"1","author":"KC Chang","year":"1978","unstructured":"Chang KC, Bell TD, Lauer BA, Chai H. Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet. 1978;1:1132\u20133.","journal-title":"Lancet"},{"key":"469_CR28","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0773.1999.tb02016.x","volume":"85","author":"NH Seppala","year":"1999","unstructured":"Seppala NH, Leinonen EV, Lehtonen ML, Kivisto KT. Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients. Pharmacol Toxicol. 1999;85:244\u20136.","journal-title":"Pharmacol Toxicol"},{"key":"469_CR29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/1047-2797(94)90102-3","volume":"4","author":"J Schwartz","year":"1994","unstructured":"Schwartz J, Weiss ST. Cigarette smoking and peripheral blood leukocyte differentials. Ann Epidemiol. 1994;4:236\u201342.","journal-title":"Ann Epidemiol"},{"key":"469_CR30","first-page":"1","volume":"220","author":"CR McGrath","year":"1982","unstructured":"McGrath CR, Hitchcock DC, van Assendelft OW. Total white blood cell counts for persons ages 1\u201374\u00a0years with differential leukocyte counts for adults ages 25\u201374\u00a0years: United States, 1971\u201375. Vital Health Stat 11. 1982;220:1\u201336.","journal-title":"Vital Health Stat 11"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-017-0469-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-017-0469-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-017-0469-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T22:00:35Z","timestamp":1750888835000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-017-0469-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,25]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1007\/s40263-017-0469-1","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,25]]}}}